Please login or sign up to post and edit reviews.
Coronavirus update | Why is India pushing ahead with Hydroxychloroquine?
Publisher |
The Hindu
Media Type |
audio
Podknife tags |
India
News & Politics
Categories Via RSS |
News
News Commentary
Publication Date |
May 26, 2020
Episode Duration |
00:19:08
The Indian Council for Medical Research said on May 26 that no major side-effects of Hydroxychloroquine have been found in studies in India and its use should be continued in preventive treatment for COVID-19. This all comes in the backdrop of the World Health Organization (WHO) suspending the testing of the drug in COVID-19 patients temporarily in its global study following safety concerns. Why is India pushing ahead with the drug and what are the kinds of trials it is running to test its efficacy? Guests: Jacob Koshy, Deputy Science Editor, The Hindu. Find the In Focus podcast on Spotify, Apple Podcasts and Stitcher. Search for In Focus by The Hindu.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review